CRAWLEY, England, May 20, 2026 /PRNewswire/ — Leo Cancer Care today announced that its flagship Marie® upright radiotherapy system has received CE marking, clearing the way for commercial deployment across Europe and marking a significant advancement in how radiotherapy can be delivered. The approval brings to Europe an upright treatment technology that has already gained clinical momentum in the United States.

For decades, radiotherapy has required patients to lie flat and remain still, an approach that has shaped everything from system design to clinical workflows – Marie® rethinks that convention entirely. By enabling treatment in an upright position, Leo Cancer Care is introducing a new paradigm: one designed to truly put the patient at the centre of care.